The efficacy of dopamine agonists or monoamine oxidase type B inhibitors as monotherapy in patients with early Parkinson disease: A network meta-analysis

被引:0
|
作者
Chuang, C. S. C.
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
1380
引用
收藏
页码:S604 / S604
页数:1
相关论文
共 50 条
  • [1] Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson’s disease: a multiple treatment comparison meta-analysis
    Caroline D. Binde
    Ingunn F. Tvete
    Jørund I. Gåsemyr
    Bent Natvig
    Marianne Klemp
    European Journal of Clinical Pharmacology, 2020, 76 : 1731 - 1743
  • [2] Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson's disease: a multiple treatment comparison meta-analysis
    Binde, Caroline D.
    Tvete, Ingunn F.
    Gasemyr, Jorund, I
    Natvig, Bent
    Klemp, Marianne
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (12) : 1731 - 1743
  • [3] Effects and Safety of Monoamine Oxidase-B Inhibitors for Early Parkinson's Disease: A Network Meta-Analysis
    Wang, Yaping
    Wang, Zhiyun
    EUROPEAN NEUROLOGY, 2024,
  • [4] Cost-Effectiveness of Dopamine Agonists and Monoamine Oxidase B Inhibitors in Early Parkinson's Disease
    McIntosh, Emma
    Kent, Seamus
    Gray, Alastair
    Clarke, Carl E.
    Williams, Adrian
    Jenkinson, Crispin
    Ives, Natalie
    Patel, Smitaa
    Rick, Caroline
    Wheatley, Keith
    Gray, Richard
    MOVEMENT DISORDERS, 2021, 36 (09) : 2136 - 2143
  • [5] Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patients
    Ives, NJ
    Stowe, RL
    Marro, J
    Counsell, C
    Macleod, A
    Clarke, CE
    Gray, R
    Wheatley, K
    BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7466): : 593 - 596B
  • [6] A multiple treatment comparison meta-analysis of monoamine oxidase type B inhibitors for Parkinson's disease
    Binde, C. D.
    Tvete, I. F.
    Gasemyr, J.
    Natvig, B.
    Klemp, M.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (09) : 1917 - 1927
  • [7] Comparative efficacy and safety of monoamine oxidase type B inhibitors plus channel blockers and monoamine oxidase type B inhibitors as adjuvant therapy to levodopa in the treatment of Parkinson's disease: a network meta-analysis of randomized controlled trials
    Yan, Rui
    Cai, Huihui
    Cui, Yusha
    Su, Dongning
    Cai, Guoen
    Lin, Fabin
    Feng, Tao
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (04) : 1118 - 1134
  • [8] Dopamine agonists versus levodopa monotherapy in early Parkinson's disease for the potential risks of motor complications: A network meta-analysis
    Zhang, Qian
    Chen, XiangTing
    Chen, FeiFei
    Wen, SiYuan
    Zhou, ChangQing
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 954
  • [9] Dopamine agonists in the treatment of early Parkinson's disease: A meta-analysis
    Baker, William L.
    Silver, Dee
    White, C. Michael
    Kluger, Jeffrey
    Aberle, Jeffrey
    Patel, Aarti A.
    Coleman, Craig I.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 (04) : 287 - 294
  • [10] Monoamine Oxidase B Inhibitors in Parkinson's Disease
    Dezsi, Livia
    Vecsei, Lzszlo
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2017, 16 (04) : 425 - 439